Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines

Biochemical and Biophysical Research Communications

Volumn 402, Issue 4, 2010, Pages 808-812

  Matyas, Gary R ^a   Wieczorek, Lindsay ^b   Bansal, Divya ^b   Chenine, Agnes Laurence ^b   Sanders Buell, Eric ^b   Tovanabutra, Sodsai ^b   Kim, Jerome H ^a   Polonis, Victoria ^a   Alving, Carl R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Antibodies to phospholipids; Chemokines; HIV 1 neutralizing antibodies; Liposomes; Peripheral blood mononuclear cells; Phosphoinositides

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BIPHOSPHATE; UNCLASSIFIED DRUG; WR 321;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOPLASM; DRUG BINDING; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CHEMOKINES; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; PHOSPHATIDYLINOSITOLS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 78649448853     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.124     Document Type: Article

References (28)

1. Polonis V.R., Brown B.K., RosaBorges A., Zolla-Pazner S., Dimitrov D.S., Zhang M.Y., Barnett S.W., Ruprecht R.M., Scarlatti G., Fenyo E.M., Montefiori D.C., McCutchan F.E., Michael N.L. Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 2008, 375:315-320.
2. Brown B.K., Karasavvas N., Beck Z., Matyas G.R., Birx D.L., Polonis V.R., Alving C.R. Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites. J. Virol. 2007, 81:2087-2091.
3. Matyas G.R., Wieczorek L., Beck Z., Ochsenbauer-Jambor C., Kappes J.C., Michael N.L., Polonis V.R., Alving C.R. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes. AIDS 2009, 23:2069-2077.
4. Beck Z., Karasawas N., Tong J., Matyas G.R., Rao M., Alving C.R. Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate. Biochem. Biophys. Res. Commun. 2007, 354:747-751.
5. Matyas G.R., Beck Z., Karasawas N., Alving C.R. Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. Biochim. Biophys. Acta 2009, 1788:660-665.
6. Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443:651-657.
7. Chan R., Uchil P.D., Jin J., Shui G., Ott D.E., Mothes W., Wenk M.R. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 2008, 82:11228-11238.
8. Ono A., Ablan S.D., Lockett S.J., Nagashima K., Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. USA 2004, 101:14889-14894.
9. Saad J.S., Miller J., Tai J., Kim A., Ghanam R.H., Summers M.F. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. USA 2006, 103:11364-11369.
10. Chukkapalli V., Hogue I.B., Boyko V., Hu W.S., Ono A. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J. Virol. 2008 Mar, 82(5):2405-2417.
11. Ono A. HIV-1 assembly at the plasma membrane. Vaccine 2010, 28(Supp. l2):B55-B59.
12. Moody M.A., Liao H.X., Alam S.M., Scearce R.M., Plonk M.K., Kozink D.M., Drinker M.S., Zhang R., Xia S.M., Sutherland L.L., Tomaras G.D., Giles I.P., Kappes J.D., Ochsenbauer-Jambor C., Edmonds T.G., Scares M., Barbero G., Forthal D.N., Landucci G., Chang C., King S.W., Kavlie A., Denny T.N., Hwang K.K., Chen P.P., Thorpe P.E., Montefiori D.C., Haynes B.F. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines. J. Exp. Med. 2010, 207:763-776.
13. Levy J.A. HIV and the Pathogenesis of AIDS 2007, ASM Press, Washington, pp. 286-288. 3rd ed.
14. Karasawas N., Beck Z., Tong J., Matyas G.R., Rao M., McCutchan F.E., Michael N.L., Alving C.R. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes. Biochem. Biophys. Res. Commun. 2008, 366:982-987.
15. Wassef N.W., Alving C.R., Richards R.L. Liposomes as carriers for vaccines. Immunomethods 1994, 4:217-222.
16. T.G. Edmonds, H. Ding, X. Yuan, Q. Wei, K.S. Smith, J.A. Conway, L. Wieczorek, B. Brown, V. Polonis, J.T. West, D.C. Montefiori, J.C. Kappes, C. Ochsenbauer, Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC, Virology (2010), doi:10.1016/j.virol.2010.08.028.
17. Chenine A., Sanders-Buell E., Wieczorek L., Kim J., Polonis V., Tovanabutra S. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC. Retrovirology 2009, 6(Suppl. 3):P361.
18. Wassef N.M., Roerdink F., Swartz G.M., Lyon J.A., Berson B.J., Alving C.R. Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes. Mol. Immunol. 1984, 21:863-868.
19. Miyazawa A., Umeda M., Horikoshi T., Yanagisawa K., Yoshioka T., Inoue K. Production and characterization of monoclonal antibodies that bind to phosphatidylinositol 4,5-bisphosphate. Mol. Immunol. 1988, 25:1025-1031.
20. Fukami K., Matsuoka K., Nakanishi O., Yamakawa A., Kawai S., Takenawa T. Antibody to phosphatidylinositol 4,5-bisphosphate inhibits oncogene-induced mitogenesis. Proc. Natl. Acad. Sci. USA 1988, 85:9057-9061.
21. Alving B.M., Banerji B., Fogler W.E., Alving C.R. Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate. Clin. Exp. Immunol. 1987, 69:403-408.
22. Matuoka K., Fukami K., Nakanishi O., Kawai S., Takenawa T. Mitogenesis in response to PDGF and bombesin abolished by microinjection of antibody to PIP2. Science 1988, 239:640-643.
23. Uno I., Fukami K., Kato H., Takenawa T., Ishikawa T. Essential role for phosphatidylinositol 4,5-bisphosphate in yeast cell proliferation. Nature 1988, 333:188-190.
24. Noel J., Fukami K., Hill A.M., Capiod T. Oscillations of cytosolic free calcium concentration in the presence of intracellular antibodies to phosphatidylinositol 4,5-bisphosphate in voltage-clamped guinea-pig hepatocytes. Biochem. J. 1992, 288(Pt. 2):357-360.
25. Gilmore A.P., Burridge K. Regulation of vinculin binding to talin and actin by phosphatidylinositol-4-5-bisphosphate. Nature 1996, 381:531-535.
26. Yamaguchi H., Yoshida S., Muroi E., Kawamura M., Kouchi Z., Nakamura Y., Sakai R., Fukami K. Phosphatidylinositol 4,5-bisphosphate and PIP5-kinase Iα are required for invadopodia formation in human breast cancer cells. Cancer Sci. 2010, 101:1632-1638.
27. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 2002, 14:129-135.
28. Hsu N.Y., Ilnytska O., Belov G., Santiana M., Chen Y.H., Takvorian P.M., Pau C., van der Schaar H., Kaushik-Basu N., Balla T., Cameron C.E., Ehrenfeld E., van Kuppeveld F.J., Altan-Bonnet N. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 2010, 141(5):799-811.